Heparanase expression upregulates platelet adhesion activity and thrombogenicity

Oncotarget

Volumn 7, Issue 26, 2016, Pages 39486-39496

  Cui, Hao ^a   Tan, Ying Xia ^a,b   Österholm, Cecilia ^c,d   Zhang, Xiao ^e   Hedin, Ulf ^c   Vlodavsky, Israel ^f   Li, Jin Ping ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^c KAROLINSKA INSTITUTE   (Sweden)

^d NOVA SOUTHEASTERN UNIVERSITY   (United States)

^e UPPSALA UNIVERSITY   (Sweden)

^f TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Heparan sulfate; Heparanase; Platelet; Platelet adhesion; Thrombosis

Indexed keywords

BETA1 INTEGRIN; BETA3 INTEGRIN; HEPARANASE; PADGEM PROTEIN; BETA GLUCURONIDASE; CHLORIDE; FERRIC CHLORIDE; FERRIC ION; GLYCOSAMINOGLYCAN; HEPARAN SULFATE; SELENOPROTEIN P; SELP PROTEIN, HUMAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; C57BL MOUSE; CAROTID ARTERY THROMBOSIS; CELL SPREADING; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; METASTASIS; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION; THROMBOGENICITY; UPREGULATION; ANIMAL; CAROTID ARTERY; CELL SEPARATION; CHEMISTRY; CROSS BREEDING; CYTOLOGY; ERYTHROCYTE; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; MALE; METABOLISM; PATHOLOGY; THROMBOCYTE; THROMBOSIS; TRANSGENIC MOUSE;

ANIMALS; BLOOD PLATELETS; CAROTID ARTERIES; CELL SEPARATION; CHLORIDES; CROSSES, GENETIC; ERYTHROCYTES; FEMALE; FERRIC COMPOUNDS; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GLUCURONIDASE; GLYCOSAMINOGLYCANS; HEPARITIN SULFATE; HUMANS; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; P-SELECTIN; PLATELET ACTIVATION; PLATELET ADHESIVENESS; SELENOPROTEIN P; THROMBOSIS; UP-REGULATION;

EID: 84982973142     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.8960     Document Type: Article

References (26)

1. Jackson SP. The growing complexity of platelet aggregation. Blood. 2007; 109:5087-5095.
2. Reed GL, Fitzgerald ML and Polgar J. Molecular mechanisms of platelet exocytosis: insights into the "secrete" life of thrombocytes. Blood. 2000; 96:3334-3342.
3. Yahalom J, Eldor A, Biran S, Fuks Z and Vlodavsky I. Platelet-tumor cell interaction with the subendothelial extracellular matrix: relationship to cancer metastasis. Radiother Oncol. 1985; 3:211-225.
4. Goubran HA, Stakiw J, Radosevic M and Burnouf T. Platelet-cancer interactions. Semin Thromb Hemost. 2014; 40:296-305.
5. Wasteson A, Hook M and Westermark B. Demonstration of a platelet enzyme, degrading heparan sulphate. FEBS letters. 1976; 64:218-221.
6. Vlodavsky I, Beckhove P, Lerner I, Pisano C, Meirovitz A, Ilan N and Elkin M. Significance of heparanase in cancer and inflammation. Cancer Microenviron. 2012; 5:115-132.
7. Vlodavsky I, Elkin M, Abboud-Jarrous G, Levi-Adam F, Fuks L, Shafat I and Ilan N. Heparanase: one molecule with multiple functions in cancer progression. Connect Tissue Res. 2008; 49:207-210.
8. Vlodavsky I, Eldor A, Haimovitz-Friedman A, Matzner Y, Ishai-Michaeli R, Lider O, Naparstek Y, Cohen IR and Fuks Z. Expression of heparanase by platelets and circulating cells of the immune system: possible involvement in diapedesis and extravasation. Invasion Metastasis. 1992; 12:112-127.
9. Nadir Y and Brenner B. Heparanase procoagulant activity. Thrombosis research. 2012; 129 Suppl 1:S76-79.
10. Escobar Galvis ML, Jia J, Zhang X, Jastrebova N, Spillmann D, Gottfridsson E, van Kuppevelt TH, Zcharia E, Vlodavsky I, Lindahl U and Li JP. Transgenic or tumor-induced expression of heparanase upregulates sulfation of heparan sulfate. Nat Chem Biol. 2007; 3:773-778.
11. Zhang X, Wang B, O'Callaghan P, Hjertstrom E, Jia J, Gong F, Zcharia E, Nilsson LN, Lannfelt L, Vlodavsky I, Lindahl U and Li JP. Heparanase overexpression impairs inflammatory response and macrophage-mediated clearance of amyloid-beta in murine brain. Acta Neuropathol. 2012; 124:465-478.
12. Massena S, Christoffersson G, Hjertstrom E, Zcharia E, Vlodavsky I, Ausmees N, Rolny C, Li JP and Phillipson M. A chemotactic gradient sequestered on endothelial heparan sulfate induces directional intraluminal crawling of neutrophils. Blood. 2010; 116:1924-1931.
13. Baker AB, Gibson WJ, Kolachalama VB, Golomb M, Indolfi L, Spruell C, Zcharia E, Vlodavsky I and Edelman ER. Heparanase regulates thrombosis in vascular injury and stent-induced flow disturbance. J Am College Cardiol. 2012; 59:1551-1560.
14. Rossaint J, Herter JM, Van Aken H, Napirei M, Doring Y, Weber C, Soehnlein O and Zarbock A. Synchronized integrin engagement and chemokine activation is crucial in neutrophil extracellular trap-mediated sterile inflammation. Blood. 2014; 123:2573-2584.
15. Franco AT, Corken A and Ware J. Platelets at the interface of thrombosis, inflammation, and cancer. Blood. 2015; 126:582-588.
16. Eldor A, Bar-Ner M, Yahalom J, Fuks Z and Vlodavsky I. Role of heparanase in platelet and tumor cell interactions with the subendothelial extracellular matrix. Semin Thromb Hemost. 1987; 13:475-488.
17. Zcharia E, Metzger S, Chajek-Shaul T, Aingorn H, Elkin M, Friedmann Y, Weinstein T, Li JP, Lindahl U and Vlodavsky I. Transgenic expression of mammalian heparanase uncovers physiological functions of heparan sulfate in tissue morphogenesis, vascularization, and feeding behavior. Faseb J. 2004; 18:252-263.
18. Woulfe DS, Lilliendahl JK, August S, Rauova L, Kowalska MA, Abrink M, Pejler G, White JG and Schick BP. Serglycin proteoglycan deletion induces defects in platelet aggregation and thrombus formation in mice. Blood. 2008; 111:3458-3467.
19. Koenig A, Norgard-Sumnicht K, Linhardt R and Varki A. Differential interactions of heparin and heparan sulfate glycosaminoglycans with the selectins. Implications for the use of unfractionated and low molecular weight heparins as therapeutic agents. J Clin Invest. 1998; 101:877-889.
20. Borsig L, Vlodavsky I, Ishai-Michaeli R, Torri G and Vismara E. Sulfated hexasaccharides attenuate metastasis by inhibition of P-selectin and heparanase. Neoplasia. 2011; 13:445-452.
21. Petzold T, Ruppert R, Pandey D, Barocke V, Meyer H, Lorenz M, Zhang L, Siess W, Massberg S and Moser M. beta1 integrin-mediated signals are required for platelet granule secretion and hemostasis in mouse. Blood. 2013; 122:2723-2731.
22. Qi C, Wei B, Zhou W, Yang Y, Li B, Guo S, Li J, Ye J, Li J, Zhang Q, Lan T, He X, Cao L, Zhou J, Geng J and Wang L. P-selectin-mediated platelet adhesion promotes tumor growth. Oncotarget. 2015; 6:6584-6596. doi:10.18632/oncotarget.3164.
23. Franchini M and Mannucci PM. Venous and arterial thrombosis: different sides of the same coin? Eur J Intern Med. 2008; 19:476-481.
24. Yahalom J, Eldor A, Fuks Z and Vlodavsky I. Degradation of sulfated proteoglycans in the subendothelial extracellular matrix by human platelet heparitinase. J Clin Invest. 1984; 74:1842-1849.
25. Pisano C, Vlodavsky I, Ilan N and Zunino F. The potential of heparanase as a therapeutic target in cancer. Biochem Pharmacol. 2014; 89:12-19.
26. Bombeli T, Schwartz BR and Harlan JM. Adhesion of activated platelets to endothelial cells: evidence for a GPIIbIIIa-dependent bridging mechanism and novel roles for endothelial intercellular adhesion molecule 1 (ICAM-1), alphavbeta3 integrin, and GPIbalpha. J Exp Med. 1998; 187:329-339.